Myrtelle is a patient-centered, innovation-driven gene therapy company transforming the treatment of neurological diseases. Our mission is to develop and deliver novel treatments for devastating disorders of the central nervous system for which few, if any, treatment options exist.
We envision a world in which patients with rare CNS diseases can access treatments that improve their quality of life & longevity.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.